Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Respiratory Journal

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/13993003.01267-2017PMID 29074546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Terrible Beauty: A short history of NICE the National Institute for Health and Care Excellence

  2017cited by this paper
• First evaluation of QuantiFERON-TB Gold Plus performance in contact screening

  2016cited by this paper
• Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country

  2016cited by this paper
• First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.

  2016cited by this paper
• Correction: Occupational Screening for Tuberculosis and the Use of a Borderline Zone for Interpretation of the IGRA in German Healthcare Workers

  2015cited by this paper
• Occupational Screening for Tuberculosis and the Use of a Borderline Zone for Interpretation of the IGRA in German Healthcare Workers

  2014cited by this paper
• IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers

  2013cited by this paper
• Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States.

  2012cited by this paper
• Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review

  2012cited by this paper
• Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare Workers

  2012cited by this paper
• Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program.

  2012cited by this paper
• Specificity of a whole blood IGRA in German nursing students

  2011cited by this paper
• Serial testing with an interferon-γ release assay in German healthcare workers

  2010cited by this paper
• Serial testing with the interferon-γ release assay in Portuguese healthcare workers

  2010cited by this paper
• Short-Term Reproducibility of a Commercial Interferon Gamma Release Assay

  2009cited by this paper
• Within-Subject Variability of Interferon-g Assay Results for Tuberculosis and Boosting Effect of Tuberculin Skin Testing: A Systematic Review

  2009cited by this paper
• Serial Testing for Tuberculosis: Can We Make Sense of T Cell Assay Conversions and Reversions?

  2007cited by this paper
• QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?

  2006cited by this paper

• Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS -infectious disease group.

  2025cites this paper
• Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings

  2025cites this paper
• Refining the diagnostic approach to latent tuberculosis Infection with Quantiferon gold plus: A retrospective analysis of borderline results

  2025influential citation
• Repeat testing or additional tuberculin skin tests for management of indeterminate results of interferon-gamma release assays: a systematic review and meta-analysis

  2025cites this paper
• Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes

  2024cites this paper
• HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing

  2024cites this paper
• Clinical Evaluation of Two Interferon-Gamma Release Assays for Diagnostic Tests of Tuberculosis Infection in a Tertiary Hospital: Clinical Evaluation of Two IGRAs for TB Infection

  2024cites this paper
• Latent Tuberculosis Infection Amongst Allogeneic Hematopoietic Stem Cell Transplant Recipients: The Impact of Routine Pretransplant Review by a Transplant Infectious Diseases Physician

  2024influential citation
• Indeterminate Result of Interferon‐γ Release Assay—A Risk Factor of Mortality for COVID‐19 and Non‐COVID‐19 Respiratory Infections

  2024cites this paper
• Retrospective data analysis on the prevalence and demographic risk factors for latent tuberculosis infection (LTBI) cases from a private laboratory in Malaysia.

  2024cites this paper
• Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis

  2023cites this paper
• Exploration and improvement of QuantiFERON-TB assay in patients with indeterminate results in clinical practice: A head-to-head study.

  2023cites this paper
• Current status and future landscape of diagnosing tuberculosis infection.

  2023cites this paper
• Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection

  2023influential citation
• Beyond QuantiFERON-TB Results, the Added Value of a Weak Mitogen Response

  2022cites this paper
• In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production

  2022cites this paper
• Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management

  2022cites this paper
• IGRA test for TB in COVID-19: role of corticosteroids

  2022cites this paper
• Screening and testing for latent tuberculosis infection among patients who are immunocompromised

  2022cites this paper
• Evaluation of ichroma™ COVID-19 interferon gamma release assay for detection of vaccine-induced immunity in healthcare workers

  2022cites this paper
• The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-γ Release Assay Results

  2021cites this paper
• Evaluation of the Fully Automated Chemiluminescence Analyzer Liaison XL for the Performance of the QuantiFERON-TB Gold Plus Assay in an Area with a Low Incidence of Tuberculosis

  2021cites this paper
• Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease

  2021cites this paper
• Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease

  2021cites this paper
• LATENT TUBERCULOSIS INFECTION AND CORONAVIRUS INFECTION

  2021cites this paper
• The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers

  2020cites this paper
• Predictors of Discordant Tuberculin Skin test and QuantiFERON-TB Gold In-Tube Results in Eastern China: A Population-based, Cohort Study.

  2020cites this paper
• Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy

  2020cites this paper
• Evaluation of QuantiFERON-TB Gold Plus on Liaison XL in a Low-Tuberculosis-Incidence Setting

  2020cites this paper
• Screening for acquired latent tuberculosis in rheumatoid arthritis patients on tumor necrosis factor inhibition therapy in Southern California

  2020cites this paper
• The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

  2020cites this paper
• Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la infección tuberculosa en pacientes con enfermedad inflamatoria intestinal

  2020cites this paper
• Rapid route design of AZD7594

  2019cites this paper
• Incidence of active tuberculosis in rural China.

  2018cites this paper
• Update in Tuberculosis and Nontuberculous Mycobacteria 2017

  2018cites this paper
• Borderline QuantiFERON results and the distinction between specific responses and test variability.

  2018cites this paper